- About
- Projects
- Column 1
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Food & Nutrition
- Column 2
- Column 1
- News and Events
- Expanded Access eRequest
Considerations for Buprenorphine Initiation and Maintenance Care
Considerations for Buprenorphine Initiation and Maintenance Care
Wednesday, May 10, 2023, 1 – 4:45 pm ET
Thursday, May 11, 2023, 1 – 4:30 pm ET
What is Narcan? The opioid overdose spray, explained. - Vox
A long-sought tool in the fight against America’s opioid crisis is becoming available later this year: Narcan, the nasal spray that can stop opioid overdoses as they are happening, will finally be sold over the counter.
FDA Approves Opioid Overdose Treatment Narcan for Over-the-Counter Sales - Rolling Stone
AN OVER-THE-COUNTER NASAL spray version of Narcan, the medication used to reverse the effects of an opioid overdose, was officially approved by the Food and Drug Administration today, March 29.
Drug overdose antidote Narcan goes over-the-counter - The Washington Post
Narcan, the lifesaving nasal spray that reverses opioid overdoses, has been approved for purchase without a prescription, the Food and Drug Administration announced on Wednesday.
RAISE: Technical Challenges in the Transfer of Information
RAISE: Technical Challenges in the Transfer of Information
Thursday, April 6, 2023
2-3 PM ET
Over-the-Counter Narcan Could Save More Lives. But Price and Stigma Are Obstacles. - New York Times
If Narcan, the nasal spray that saves lives by reversing opioid overdoses, receives approval to be sold over the counter, public health officials hope the palm-size plunger could one day become as commonplace as a kitchen fire extinguisher.
2023 Innovations in Regulatory Science Awards
Join the Reagan-Udall Foundation for the FDA at the 2023 Innovations in Regulatory Science Awards—celebrating leadership, scientific innovation, and advocacy advancing public health.
Biden officials flood the Hill - POLITICO
FDA ON THE HILL: Califf on Wednesday will testify before the House Appropriations Committee on Biden’s fiscal 2024 budget.
2023 Annual Public Meeting
Each year, the Reagan-Udall Foundation for the FDA conducts an Annual Public Meeting of its Board of Directors to share information about our activities in support of the U.S. Food and Drug Administration. By bringing together a variety of perspectives, the annual public meeting facilitates engagement between FDA and external stakeholders including patients and consumers, regulated industry, health care providers, academics, and others dedicated to improving America's public health.